ATE382334T1 - Gelatine-freie schell dispergierende dosisformen - Google Patents

Gelatine-freie schell dispergierende dosisformen

Info

Publication number
ATE382334T1
ATE382334T1 AT00908371T AT00908371T ATE382334T1 AT E382334 T1 ATE382334 T1 AT E382334T1 AT 00908371 T AT00908371 T AT 00908371T AT 00908371 T AT00908371 T AT 00908371T AT E382334 T1 ATE382334 T1 AT E382334T1
Authority
AT
Austria
Prior art keywords
dosage forms
solid dosage
active ingredient
gelatine
dose forms
Prior art date
Application number
AT00908371T
Other languages
English (en)
Inventor
Leon Paul Grother
Owen James Murray
Richard Green
Patrick Kearney
Original Assignee
Scherer Corp R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Corp R P filed Critical Scherer Corp R P
Application granted granted Critical
Publication of ATE382334T1 publication Critical patent/ATE382334T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00908371T 1999-01-27 2000-01-27 Gelatine-freie schell dispergierende dosisformen ATE382334T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9901819.4A GB9901819D0 (en) 1999-01-27 1999-01-27 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE382334T1 true ATE382334T1 (de) 2008-01-15

Family

ID=10846608

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00908371T ATE382334T1 (de) 1999-01-27 2000-01-27 Gelatine-freie schell dispergierende dosisformen

Country Status (24)

Country Link
EP (1) EP1154757B1 (de)
JP (1) JP4863336B2 (de)
KR (1) KR100852015B1 (de)
CN (1) CN1193740C (de)
AT (1) ATE382334T1 (de)
AU (1) AU768121B2 (de)
BG (1) BG65413B1 (de)
CA (1) CA2360647C (de)
CY (1) CY1107384T1 (de)
CZ (1) CZ301249B6 (de)
DE (1) DE60037653T2 (de)
DK (1) DK1154757T3 (de)
ES (1) ES2298129T3 (de)
GB (1) GB9901819D0 (de)
HU (1) HU226557B1 (de)
IL (2) IL144412A0 (de)
IS (1) IS2678B (de)
NO (1) NO331253B1 (de)
PL (1) PL197462B1 (de)
PT (1) PT1154757E (de)
RU (1) RU2242968C2 (de)
TR (1) TR200102504T2 (de)
WO (1) WO2000044351A1 (de)
ZA (1) ZA200105930B (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9904049D0 (en) * 1999-02-22 1999-04-14 Quadrant Holdings Cambridge Rapidly-soluble compositions
US7550156B2 (en) 2001-11-23 2009-06-23 Rohm And Haas Company Optimised pellet formulations
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible
PT1501534E (pt) * 2002-05-07 2006-09-29 Ferring Bv Formulacoes farmaceuticas
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
DE10237459A1 (de) * 2002-08-16 2004-02-26 Beiersdorf Ag Wirkstoffhaltige kosmetische Zubereitung
WO2004047793A1 (en) * 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
UA93479C2 (en) * 2002-11-26 2011-02-25 Альк-Абелло A/C Allergen dosage form
RU2372074C2 (ru) * 2002-11-26 2009-11-10 Альк-Абелло А/С Лекарственная форма, содержащая аллерген
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
AU2004216559B2 (en) * 2003-02-28 2010-05-27 Alk-Abello A/S Dosage form having a saccharide matrix
ITRM20030288A1 (it) * 2003-06-10 2004-12-11 Valerio Cioli Somministrazione sublinguale di antinfiammatori non steroidei (fans)
CA2866501A1 (en) 2003-11-10 2005-05-26 Allergan, Inc. Pharmaceutical compositions including low dosages of desmopressin
DE20321887U1 (de) 2003-11-10 2012-01-20 Allergan, Inc. Arzneimittel umfassend niedrige Dosierungen von Desmopressin
ES2260563T3 (es) 2003-11-13 2006-11-01 Ferring B.V. Paquete de blister y forma farmaceutica solida para ello.
US20060210590A1 (en) 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
RU2370268C2 (ru) * 2005-05-25 2009-10-20 Лабораториос Баго С.А. Способ получения фармацевтической композиции для орального введения, обладающей улучшенной биодоступностью биологически активного действующего лекарственного вещества, и фармацевтическая композиция, полученная этим способом
EP1933867A1 (de) 2005-10-04 2008-06-25 Alk-Abello A/S Feste impfstoff-formulierung
CN101548958B (zh) * 2008-04-03 2012-10-17 万特制药(海南)有限公司 一种含有盐酸特比萘芬的分散片
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
SI2712622T1 (sl) 2008-05-21 2016-10-28 Ferring B.V. Orodisperzibilni dezmopresin za povečanje začetnega obdobja spanja nemotenega z nokturijo
DE102008051579A1 (de) * 2008-10-14 2010-04-15 Rhodia Acetow Gmbh Biologisch abbaubarer Kunststoff und Verwendung desselben
AU2010249615B2 (en) 2009-05-19 2013-07-18 Celgene Corporation Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione
PT2442821T (pt) 2009-06-18 2017-09-29 Allergan Inc Administração segura de desmopressina
EP2482822B1 (de) 2009-10-01 2018-08-01 Adare Pharmaceuticals, Inc. Oral verabreichte corticosteroid-zusammensetzungen
TR201902233T4 (tr) * 2009-10-30 2019-03-21 Ix Biopharma Ltd Hızlı çözünen katı dozaj formu.
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
US10548839B2 (en) * 2010-03-16 2020-02-04 Wei Tian Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form
JO3112B1 (ar) 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
MX2012010555A (es) * 2010-03-29 2012-10-05 Firmenich & Cie Ingrediente activo cristalino secado por rociado.
MX341200B (es) 2010-03-29 2016-08-11 Ferring Bv Composicion farmaceutica de disolucion rapida.
EP3095441B1 (de) * 2010-10-08 2020-12-02 R.P. Scherer Technologies, LLC Orale schnell lösliche darreichungsform eines impfstoffes unter verwendung von stärke
BR112014005134A2 (pt) 2011-09-16 2017-04-18 Ferring Bv composição farmacêutica de dissolução rápida
RU2497505C1 (ru) * 2012-11-07 2013-11-10 Максим Эдуардович Запольский Новая лекарственная композиция для лечения болевого синдрома при спазме гладкой мускулатуры
RU2503447C1 (ru) * 2012-11-20 2014-01-10 Максим Эдуардович Запольский Лекарственное средство в форме ородисперсной таблетки и способ получения лекарственного средства
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
EP2952200A1 (de) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen zur vorbeugenden Behandlung von Allergien
CN106259891A (zh) * 2015-05-28 2017-01-04 上海旺旺食品集团有限公司 一种益生菌口含片及其制备方法
RU2674765C2 (ru) * 2016-10-03 2018-12-13 Михаил Лукич Ткаченко Антигрибковая композиция эвтектического типа (варианты)
SG10202107367SA (en) 2016-12-31 2021-08-30 Bioxcel Therapeutics Inc Use of sublingual dexmedetomidine for the treatment of agitation
ES3004544T3 (en) 2018-06-27 2025-03-12 Bioxcel Therapeutics Inc Film formulations containing dexmedetomidine and methods of producing them
US20240024288A1 (en) 2019-07-19 2024-01-25 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
NL8304133A (nl) * 1983-12-01 1985-07-01 Unilever Nv Water-in-olie emulsies die gehydrateerde zetmeelkorrels bevatten.
DE4018247A1 (de) * 1990-06-07 1991-12-12 Lohmann Therapie Syst Lts Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen
WO1995001782A2 (en) * 1993-07-09 1995-01-19 R.P. Scherer Corporation Method for making freeze dried drug dosage forms
GB9401892D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
DE69732909T2 (de) * 1996-07-12 2005-08-11 Daiichi Pharmaceutical Co., Ltd. Rasch zerfallende Pressmasse und Verfahren zu ihrer Herstellung
JP4292588B2 (ja) * 1997-01-31 2009-07-08 日産化学工業株式会社 ピリダジノン化合物類の経口製剤

Also Published As

Publication number Publication date
PL197462B1 (pl) 2008-04-30
JP2003529535A (ja) 2003-10-07
NO331253B1 (no) 2011-11-07
ES2298129T3 (es) 2008-05-16
HK1037536A1 (en) 2002-02-15
RU2242968C2 (ru) 2004-12-27
ZA200105930B (en) 2002-10-18
EP1154757A1 (de) 2001-11-21
IS2678B (is) 2010-09-15
BG65413B1 (bg) 2008-07-31
HU226557B1 (en) 2009-03-30
CA2360647A1 (en) 2000-08-03
IL144412A (en) 2006-06-11
WO2000044351A1 (en) 2000-08-03
DE60037653T2 (de) 2008-10-30
TR200102504T2 (tr) 2002-08-21
KR100852015B1 (ko) 2008-08-12
JP4863336B2 (ja) 2012-01-25
EP1154757A4 (de) 2004-01-21
KR20010111565A (ko) 2001-12-19
BG105739A (en) 2002-06-28
PT1154757E (pt) 2008-03-17
NO20013679D0 (no) 2001-07-26
CZ20012700A3 (cs) 2002-08-14
AU768121B2 (en) 2003-12-04
DK1154757T3 (da) 2008-05-13
CA2360647C (en) 2005-08-02
EP1154757B1 (de) 2008-01-02
HUP0105107A2 (en) 2002-06-29
NO20013679L (no) 2001-09-19
CN1337876A (zh) 2002-02-27
IS6023A (is) 2001-07-25
CN1193740C (zh) 2005-03-23
IL144412A0 (en) 2002-12-01
CY1107384T1 (el) 2012-01-25
CZ301249B6 (cs) 2009-12-23
AU2972900A (en) 2000-08-18
HUP0105107A3 (en) 2006-07-28
DE60037653D1 (de) 2008-02-14
GB9901819D0 (en) 1999-03-17

Similar Documents

Publication Publication Date Title
DE60037653D1 (de) Gelatine-freie schell dispergierende dosisformen
BE901994A (fr) Comprimes de principes actifs pharmaceutiques a delitement rapide, stables au stockage.
EA200001125A1 (ru) Гелеобразные фармацевтические композиции
ATE234634T1 (de) Feste pharmazeutische formulierungen enthaltend eine physische mischung aus sulphoalkylethercyclodextrin und einem therapeutischen wirkstoff
NO962040L (no) Mikroinnkapslede 3-piperidinyl-substituerte 1,2-benzisoksazoler og 1,2-benzisotiazoler
NO980669L (no) Orale raskt-opplöselige blandinger for dopaminagonister
KR950007841A (ko) 트라마돌 염을 함유하는 서방성 약물 제제
FI842528A0 (fi) Fasta farmaceutiska preparat fraon vilka frigoeringen av det aktiva aemnet sker laongsamt via reglerad yterosion.
IS2789B (is) Lyfjablöndur sem innihalda mónóamínoxídasa B hemla
BR9908371A (pt) Formulação preservante lìquida de amplo espectro, método para sua preparação, solução de iodopropargila estabilizada e processo para eliminar ou retardar o crescimento de micróbios
KR880004803A (ko) 분무 건조된 아세트아미노펜
AR018607A1 (es) Preparacion farmaceutica que en calidad de ingrediente activo contiene levotiroxina sodica, y un procedimiento para su preparacion
EA200700055A1 (ru) Препаративные формы пероральных лекарственных форм мемантина с немедленным высвобождением
ATE359248T1 (de) Rauch erzeugende zusammensetzung
TR199900584T2 (xx) Amino asit esteri i�eren azol mantar �nleyiciler.
MXPA05008711A (es) Uso de r-10-hidroxi-10,11-dihidro-carbamazepina en dolor neuropatico.
DK1216043T3 (da) Formulering med forsinket frigivelse indeholdende alfa-liponsyre-(derivater)
FR2719771B1 (fr) Compositions pharmaceutiques contenant du gemfibrozil.
EA200700979A1 (ru) Пероральные твердые лекарственные формы, содержащие низкую дозу эстрадиола
AR036323A1 (es) Formas de dosis de rapida dispersion, libres de gelatina
MXPA05012655A (es) Isomeros puros d-(17a)-13 -etil-17-hidroxi -18, 19-dinorpregn- 4-eno-20-ino -3-ona-3e -y ??3z- oxima, asi como el proceso para la sintesis de la mezcla de isomeros y los isomeros puros.
EA200100794A1 (ru) Фармацевтическая композиция, ее применение и способ получения
Lewartowski et al. The effect of menadione on sarcoplasmic reticulum Ca2plus and contractions of single guinea-pig cardiomyocytes

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1154757

Country of ref document: EP

EEFA Change of the company name